Anadys Pharmaceuticals Jumps on High Volume

Shares of Anadys Pharmaceuticals

are popping hard this afternoon on high volume. Currently, shares are higher by 10.05%, trading at $1.09. Share volume is running at 911,000 shares; the 10-day daily average volume is only 123,000 shares. There is currently no new news for Anadys Pharmaceuticals, but with a move like this you can expect some to hit the tape soon. Note that Anadys Pharmaceuticals has 1.09% short interest. Anadys Pharmaceuticals, Inc. is a biopharmaceutical company engaged in developing medicines for the treatment of hepatitis C. The company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C.